Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,574 | 5,666 | 12,473 | 7,013 | 7,413 |
| Operating Income | -6,574 | -5,666 | -12,473 | -7,013 | -7,413 |
| Other Income | -1,299 | -4,150 | -2,358 | -1,350 | -884 |
| Pre-tax Income | -7,873 | -9,816 | -14,831 | -8,363 | -8,297 |
| Net Income Continuous | -7,873 | -9,816 | -14,831 | -8,363 | -8,297 |
| Net Income | $-7,873 | $-9,816 | $-14,831 | $-8,363 | $-8,297 |
| EPS Basic Total Ops | -0.17 | -0.21 | -0.32 | -0.18 | -0.18 |
| EPS Basic Continuous Ops | -0.17 | -0.21 | -0.32 | -0.18 | -0.18 |
| EPS Diluted Total Ops | -0.17 | -0.21 | -0.32 | -0.18 | -0.18 |
| EPS Diluted Continuous Ops | -0.17 | -0.21 | -0.32 | -0.18 | -0.18 |
| EBITDA(a) | $-6,781 | $-5,754 | $-12,462 | $-6,881 | $-7,271 |